Horiuchi Y, Matsue Y, Nogi K, Onitsuka K, et al. Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: rationale for and design of the EMPA-AHF trial. Am Heart J 2022 Dec 8:S0002-8703(22)00325-8. doi: 10.1016/j.ahj.2022.
PMID: 36503007